Applied DNA Reports Second Quarter Fiscal 2022 Financial Results

Go back to Applied DNA Reports Second Quarter Fiscal 2022 Financial Results

Applied DNA Sciences (APDN) Tops Q2 EPS by 10c

May 12, 2022 4:23 PM EDT

Applied DNA Sciences (NASDAQ: APDN) reported Q2 EPS of ($0.23), $0.10 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $4.5 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

... More